It is a service private limited company based in Chandigarh, Chandigarh, India, established in 2000.
2000 | Chandigarh, Chandigarh, India | AmalgamatedMagnanimous Pharmaceuticals Private Limited, a amalgamated private limited company, was established on 17 July 2000 in Chandigarh, Chandigarh, India. Engaging in information technology services within the information and communication sector, it holds CIN: U24117CH2000PTC023840. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.25 Cr and a paid-up capital of ₹0.58 M.
It upholds a compliant status. Its leadership includes Pankaj Jaswal (Director), Virender Kumar Dhawan (Director). Past directors included Sanjeev Bhardwaj, Subhash Chand Sharma, Ankit Dhawan. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Sco - 815, Top Floor, Cabin No. - 9, Shivalik Enclave, Nac, Manimajra,, Chandigarh, Chandigarh, 160101.
U24117CH2000PTC023840
023840
17 July 2000
₹1.25 Cr
₹0.58 M
Roc Chandigarh
Unlisted
Amalgamated
Explore comprehensive insights into Magnanimous Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pankaj Jaswal | Director | 24 Jun 2021 | Current |
| Virender Kumar Dhawan | Director | 01 Mar 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Mar 2019 | Past |
| Pramod Abcsdd | Director | 24 Jul 2010 | Past |
| Pramod Abcsdd | Director | 25 Jun 2021 | Past |
| Pramod Abcsdd | Director | 02 Mar 2009 | Past |
| Pramod Abcsdd | Additional Director | 08 Aug 2011 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Magnanimous Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 7.83% increase. The company also saw a substantial improvement in profitability, with a 77.88% increase in profit. The company's net worth dipped by a decrease of 0.02%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Magnanimous Pharmaceuticals had a promoter holding of 86.46% and a public holding of 13.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Magnanimous Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Magnanimous Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Magnanimous Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Magnanimous Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
Magnanimous Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Chandigarh. was recorded as a recent event.
Pankaj Jaswal was appointed as a Director was appointed as a Director on 24 Jun 2021 & has been associated with this company since 4 years 6 months . was recorded as a recent event.
Virender Kumar Dhawan was appointed as a Director was appointed as a Director on 01 Mar 2019 & has been associated with this company since 6 years 10 months . was recorded as a recent event.
Magnanimous Pharmaceuticals Private Limited was registered on 17 Jul 2000 with Roc Chandigarh & aged 25 years 5 months as per MCA records. was recorded as a recent event.
The CIN of Magnanimous Pharmaceuticals Private Limited is U24117CH2000PTC023840.
Magnanimous Pharmaceuticals Private Limited is headquartered at Sco - 815, Top Floor, Cabin No. - 9, Shivalik Enclave, Nac, Manimajra,, Chandigarh, Chandigarh, 160101.
Magnanimous Pharmaceuticals Private Limited was incorporated on 17 July 2000.
The current directors of Magnanimous Pharmaceuticals Private Limited are
The primary industry of Magnanimous Pharmaceuticals Private Limited is Information And Communication.
Magnanimous Pharmaceuticals Private Limited is unlisted.
The authorized capital of Magnanimous Pharmaceuticals Private Limited is ₹1.25 Cr, and the paid-up capital is ₹0.58 M.
The compliance status of Magnanimous Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX